Skip to content

Clinical trials

Oppositional Defiant Disorder trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Oppositional Defiant Disorder Phase: Not applicable Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20051
20062
20071
20091
20113
20122
20144
20154
20163
20173
20183
20191
20201
20212
20226
20232
20247
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Recruiting9
Unknown status4
Not yet recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Karolinska Institutet6
Centre for Addiction and Mental Health3
University of Pittsburgh3
Florida International University2
Indiana University2
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital2
Oregon Research Institute2
University of California, San Francisco2
University of South Florida2
Yale University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Oppositional Defiant Disorder53
Conduct Disorder28
Attention Deficit Disorder with Hyperactivity20
Attention Deficit and Disruptive Behavior Disorders13
Mental Disorders7
Anxiety Disorders6
Depressive Disorder3
Sleep Initiation and Maintenance Disorders3
Autistic Disorder2
Child Behavior Disorders2

Trials

Showing 26 to 50 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.